| |
| |
|
| Insider
Information: |
Borgeson Blake |
| Relationship: |
Director |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
7,200,010 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$61,776,086 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,200,010 |
|
|
| Total
Value |
$61,776,086 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Recursion Pharmaceuticals, Inc. |
RXRX |
Director |
2024-06-03 |
7,200,010 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2021-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,688,356 |
0 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2021-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,759,054 |
|
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2021-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
6,765,304 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-05-28 |
4 |
AS |
$9.17 |
$104,943 |
D/D |
(11,447) |
7,186,913 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-05-14 |
4 |
AS |
$10.12 |
$202,934 |
D/D |
(20,054) |
7,198,360 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,097 |
7,200,010 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-04-30 |
4 |
AS |
$7.95 |
$90,964 |
D/D |
(11,447) |
7,218,414 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-04-16 |
4 |
AS |
$7.66 |
$87,725 |
D/D |
(11,447) |
7,229,861 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-04-02 |
4 |
AS |
$8.82 |
$100,942 |
D/D |
(11,447) |
7,241,308 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-03-19 |
4 |
AS |
$10.79 |
$216,423 |
D/D |
(20,054) |
7,252,755 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-03-05 |
4 |
AS |
$12.06 |
$241,805 |
D/D |
(20,054) |
7,272,809 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-02-20 |
4 |
AS |
$12.31 |
$247,125 |
D/D |
(20,054) |
7,292,863 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-02-06 |
4 |
AS |
$9.30 |
$106,489 |
D/D |
(11,447) |
7,312,917 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-01-23 |
4 |
AS |
$10.58 |
$212,083 |
D/D |
(20,054) |
7,324,364 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2024-01-09 |
4 |
AS |
$13.21 |
$273,202 |
D/D |
(20,054) |
7,344,418 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-12-26 |
4 |
AS |
$10.63 |
$213,144 |
D/D |
(20,054) |
7,364,472 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-12-12 |
4 |
AS |
$7.40 |
$84,693 |
D/D |
(11,447) |
7,384,526 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-11-28 |
4 |
AS |
$6.72 |
$76,918 |
D/D |
(11,447) |
7,395,973 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-11-14 |
4 |
AS |
$6.32 |
$56,151 |
D/D |
(8,885) |
7,407,420 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-10-31 |
4 |
AS |
$5.27 |
$46,864 |
D/D |
(8,885) |
7,416,305 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-10-17 |
4 |
AS |
$6.58 |
$58,483 |
D/D |
(8,885) |
7,425,190 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-10-03 |
4 |
AS |
$7.29 |
$64,778 |
D/D |
(8,885) |
7,434,075 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-09-19 |
4 |
AS |
$8.36 |
$74,278 |
D/D |
(8,885) |
7,442,960 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-09-05 |
4 |
AS |
$8.79 |
$78,136 |
D/D |
(8,885) |
7,451,845 |
0 |
% |
|
| RXRX |
Recursion Pharmaceuticals... |
Director |
– • – |
2023-08-22 |
4 |
AS |
$8.91 |
$79,181 |
D/D |
(8,885) |
7,460,730 |
0 |
% |
|
59 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
